Establishment Labs Holdings (ESTA) EBIT (QoQ) (2017 - 2026)
Establishment Labs Holdings (ESTA) EBIT (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.67% |
| Dec 31, 2025 | 2.36% |
| Sep 30, 2025 | 71.47% |
| Jun 30, 2025 | 16.75% |
| Mar 31, 2025 | 9.23% |
| Dec 31, 2024 | -42.10% |
| Sep 30, 2024 | -40.61% |
| Jun 30, 2024 | -5.77% |
| Mar 31, 2024 | 60.05% |
| Dec 31, 2023 | -5.12% |
| Sep 30, 2023 | -53.42% |
| Jun 30, 2023 | -68.05% |
| Mar 31, 2023 | 37.99% |
| Dec 31, 2022 | -25.13% |
| Sep 30, 2022 | -1.07% |
| Jun 30, 2022 | -86.65% |
| Mar 31, 2022 | 40.48% |
| Dec 31, 2021 | -3.56% |
| Sep 30, 2021 | -95.17% |
| Jun 30, 2021 | -121.09% |